| Karlee Raye Cabral, DPT | |
|
1541 Centennial Ct, Casper, WY 82609-7304 | |
| (541) 771-2934 | |
| Not Available |
| Full Name | Karlee Raye Cabral |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 6 Years |
| Location | 1541 Centennial Ct, Casper, Wyoming |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548747165 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 1807 (Wyoming) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wind City Physical Therapy | 9830172055 | 13 |
News Archive
Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.
MAP Pharmaceuticals, Inc. today announced that the Company will present nine analyses relating to its LEVADEX™ orally inhaled migraine therapy product candidate, including analysis from the FREEDOM-301 Phase 3 trial, at the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
Two recent studies provide evidence for a new approach to vaccines to prevent infections caused by drug-resistant Staphylococcus aureus - better known as MRSA - the leading cause of skin and soft tissue, bloodstream and lung infections in the United States. One demonstrates a way to counteract the bacteria's knack for evading the immune system. The other shows how to disrupt the germ's tissue-damaging mechanism.
When flu season arrives this fall, a liquid form of Tamiflu—the most widely used anti-viral flu medication—will be available in a new, lower concentration to reduce the possibility of medication errors.
› Verified 1 days ago
| Provider Name | Wind City Physical Therapy |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1093767121 PECOS PAC ID: 9830172055 Enrollment ID: O20040609001043 |
News Archive
Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.
MAP Pharmaceuticals, Inc. today announced that the Company will present nine analyses relating to its LEVADEX™ orally inhaled migraine therapy product candidate, including analysis from the FREEDOM-301 Phase 3 trial, at the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
Two recent studies provide evidence for a new approach to vaccines to prevent infections caused by drug-resistant Staphylococcus aureus - better known as MRSA - the leading cause of skin and soft tissue, bloodstream and lung infections in the United States. One demonstrates a way to counteract the bacteria's knack for evading the immune system. The other shows how to disrupt the germ's tissue-damaging mechanism.
When flu season arrives this fall, a liquid form of Tamiflu—the most widely used anti-viral flu medication—will be available in a new, lower concentration to reduce the possibility of medication errors.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karlee Raye Cabral, DPT 6794 Ne Juniper Ridge Rd, Redmond, OR 97756-9767 Ph: (541) 771-2934 | Karlee Raye Cabral, DPT 1541 Centennial Ct, Casper, WY 82609-7304 Ph: (541) 771-2934 |
News Archive
Angiotech Pharmaceuticals, Inc., today announced the commercial launch of the Tan EndoGlide(TM) Endothelium Insertion System in the United States. Angiotech holds exclusive U.S. distribution rights to market and distribute the Tan EndoGlide Endothelium Insertion System, which it obtained in a supply agreement with privately held Network Medical Products, Ltd. Angiotech will launch the product during the American Academy of Ophthalmology meeting, to be held in San Francisco, CA on October 24-27, 2009.
MAP Pharmaceuticals, Inc. today announced that the Company will present nine analyses relating to its LEVADEX™ orally inhaled migraine therapy product candidate, including analysis from the FREEDOM-301 Phase 3 trial, at the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
A new University of Colorado at Boulder study shows the resistance of the avian flu virus to a major class of antiviral drugs is increasing through positive evolutionary selection, with researchers documenting the trend in more than 30 percent of the samples tested.
Two recent studies provide evidence for a new approach to vaccines to prevent infections caused by drug-resistant Staphylococcus aureus - better known as MRSA - the leading cause of skin and soft tissue, bloodstream and lung infections in the United States. One demonstrates a way to counteract the bacteria's knack for evading the immune system. The other shows how to disrupt the germ's tissue-damaging mechanism.
When flu season arrives this fall, a liquid form of Tamiflu—the most widely used anti-viral flu medication—will be available in a new, lower concentration to reduce the possibility of medication errors.
› Verified 1 days ago
Dr. Eva Cheros, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 4140 Centennial Hills Blvd Ste B, Casper, WY 82609 Phone: 307-265-7205 | |
Joshua J Woods, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 441 Landmark Dr, Suite 230, Casper, WY 82609 Phone: 307-337-3200 Fax: 307-448-3046 | |
Lyla Joy Mcdonald, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 300 Landmark Dr Ste B, Casper, WY 82609 Phone: 307-472-3327 | |
Mark S Daugherity, MPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 201 E 2nd St, Suite 14, Casper, WY 82601 Phone: 307-337-1624 | |
Leanne E Parks, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 4140 Centennial Hills Blvd Ste A, Casper, WY 82609 Phone: 307-265-7205 Fax: 307-235-6262 | |
Sara Jean Stier, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2121 E 2nd St Ste 100, Casper, WY 82609 Phone: 307-333-2943 | |
Daniel Arnold, Physical Therapist Medicare: Medicare Enrolled Practice Location: 2665 E 2nd St, Casper, WY 82609 Phone: 972-213-8914 |